Buspirone Hydrochloride Tablet
Product Images NDC 71335-2768

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71335-2768). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg ( Two Thirds Of A Tablet) (15mg 10mg)

Buspirone Hydrochloride 30 mg oral tablet illustrated as a white tablet scored into two parts, one side marked with "0" and the other side shaped with a notch and marked "9". No further packaging or labeling information is visible in the image.*

FDA Label Image

15 mg (the Entire Tablet) (15mg 15mg)

Buspirone Hydrochloride 30 mg oral tablet label showing an imprint code consisting of three characters: '0', '9', and '3' in separate rectangular segments on the tablet surface. The imprint aids in identifying the medication.*

FDA Label Image

5 mg (one Third Of A Tablet) (15mg 5mg)

Buspirone Hydrochloride 30 mg oral tablet label from Bryant Ranch Prepack. The image shows a simple white label marked with a single black '0' in a rounded square, indicating minimal visible branding or dosage details beyond this mark.*

FDA Label Image

7.5 Xxx (15mg 7 5)

Buspirone Hydrochloride 30 mg oral tablets in a blister pack. The tablets are oblong, white, with '0 3' imprinted on one side. The packaging is not fully visible but shows a portion of the blister strip with individual tablets.*

FDA Label Image

10 mg (one Third Of A Tablet) (30mg 10mg)

The image shows a close-up view of a single tablet labeled with the number '10' embossed on its surface, indicating the dosage strength. This corresponds to the Buspirone Hydrochloride 30 mg oral tablet by Bryant Ranch Prepack, NDC 71335-2768.*

FDA Label Image

15 mg Entire Tablet (30mg 15mg)

Buspirone Hydrochloride 30 mg oral tablet with an imprint showing the number '10' on one side. The tablet appears white and is scored to allow splitting.*

FDA Label Image

20 mg (two Thirds Of A Tablet) (30mg 20mg)

Buspirone Hydrochloride 30 mg oral tablets. The image shows a single white tablet with the imprint '10 | 10' scored on one side, indicating it can be split. No other markings, branding, or batch information is visible. Labeler is Bryant Ranch Prepack.*

FDA Label Image

30 mg (the Entire Tablet) (30mg 30mg)

Buspirone Hydrochloride 30 mg oral tablet imprinted with the code '10 10 10' divided into three sections. The white, rectangular tablet is visibly scored. No additional text or branding is present in the image.*

FDA Label Image

Break In Half (Break)

An instructional line drawing showing hands holding and breaking a tablet, demonstrating how to split a tablet into halves. The image implies proper tablet division technique but includes no text or specific product labeling.*

FDA Label Image

Label (Lbl713352768)

Buspirone Hydrochloride Tablets, USP 30 mg oral tablets label showing product NDC 71335-2768-1. The label indicates 60 tablets in the package, repackaged by Bryant Ranch Prepack and manufactured by Oxford Pharmaceuticals LLC. It includes storage instructions, a barcode, two QR codes, and child-resistant container information.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of buspirone hydrochloride. The diagram shows the molecular arrangement including a bicyclic ring system, a piperazine ring, and a pyrimidine ring with associated bonds, illustrating the active ingredient in Buspirone Hydrochloride tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.